Benzenesulfonamide compounds and their use as therapeutic agents
US9630929B2 · kind B2 · utility
11Cited by
16References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2012 |
| Grant date | Apr 25, 2017 |
| Priority date | — |
| Expiry date | Oct 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to benzensulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of sodium channel-mediated diseases or conditions, such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.